ProCE Banner Activity

COVID-19 Treatments: Present and Future

Clinical Thought
Do we already have an FDA-approved, safe, and inexpensive drug that could benefit patients with COVID-19? Take a look at these promising studies of a repurposed drug—fluvoxamine—for COVID-19.

Released: September 21, 2021

Expiration: September 20, 2022

No longer available for credit.

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Gilead Sciences, Inc.